BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 30416134)

  • 21. Clinical significance of preoperative renal function and gross hematuria for intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinoma.
    Hashimoto T; Nakashima J; Kashima T; Hirasawa Y; Shimodaira K; Gondo T; Nakagami Y; Namiki K; Horiguchi Y; Ohno Y; Ohori M; Tachibana M
    Int J Urol; 2017 Feb; 24(2):111-116. PubMed ID: 27875859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
    Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
    Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Caveolin-1 Expression in Upper Tract Urothelial Carcinoma.
    D'Andrea D; Moschini M; Foerster B; Abufaraj M; Margulis V; Karam J; Lotan Y; Raman J; Mathieu R; Rouprêt M; Karakiewicz PI; Briganti A; Haitel A; Shariat SF
    Eur Urol Focus; 2019 Jan; 5(1):97-103. PubMed ID: 28753840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. No overt influence of lymphadenectomy on cancer-specific survival in organ-confined versus locally advanced upper urinary tract urothelial carcinoma undergoing radical nephroureterectomy: a retrospective international, multi-institutional study.
    Burger M; Shariat SF; Fritsche HM; Martinez-Salamanca JI; Matsumoto K; Chromecki TF; Ficarra V; Kassouf W; Seitz C; Pycha A; Tritschler S; Walton TJ; Novara G
    World J Urol; 2011 Aug; 29(4):465-72. PubMed ID: 21630120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preoperative predictive model and nomogram for disease recurrence following radical nephroureterectomy for high grade upper tract urothelial carcinoma.
    Freifeld Y; Ghandour R; Singla N; Woldu S; Clinton T; Kulangara R; Bagrodia A; Matin SF; Petros FG; Raman JD; Robyak H; Yan J; Zhu H; Rapoport L; Lotan Y; Margulis V
    Urol Oncol; 2019 Oct; 37(10):758-764. PubMed ID: 31378586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic role of the preoperative serum albumin : globulin ratio after radical nephroureterectomy for upper tract urothelial carcinoma.
    Otsuka M; Kamasako T; Uemura T; Takeshita N; Shinozaki T; Kobayashi M; Komaru A; Fukasawa S
    Int J Urol; 2018 Oct; 25(10):871-878. PubMed ID: 30103271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of preoperative body mass index on prognosis for patients with upper urinary tract urothelial carcinoma treated with radical nephroureterectomy.
    Chen JC; Huang TH; Wei TC; Huang IS; Fan YH; Lin CC; Lin TP; Chung HJ; Lu SH; Kuo JY; Wu HHH; Chang YH; Lin ATL; Huang WJ; Huang EY
    World J Urol; 2023 Dec; 41(12):3575-3583. PubMed ID: 37924334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of tumour size on prognosis of upper urinary tract urothelial carcinoma after radical nephroureterectomy: a multi-institutional analysis of 795 cases.
    Shibing Y; Liangren L; Qiang W; Hong L; Turun S; Junhao L; Lu Y; Zhengyong Y; Yonghao J; Guangqing F; Yunxiang L; Dehong C
    BJU Int; 2016 Dec; 118(6):902-910. PubMed ID: 26935344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A multi-institutional validation of the prognostic value of the neutrophil-to-lymphocyte ratio for upper tract urothelial carcinoma treated with radical nephroureterectomy.
    Tanaka N; Kikuchi E; Kanao K; Matsumoto K; Shirotake S; Miyazaki Y; Kobayashi H; Kaneko G; Hagiwara M; Ide H; Obata J; Hoshino K; Hayakawa N; Kosaka T; Hara S; Oyama M; Momma T; Nakajima Y; Jinzaki M; Oya M
    Ann Surg Oncol; 2014 Nov; 21(12):4041-8. PubMed ID: 24912614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of urothelial carcinoma with divergent differentiation in upper urinary tract after radical nephroureterectomy without metastatic diseases: A retrospective cohort study.
    Qin C; Liang EL; Du ZY; Qiu XY; Tang G; Chen FR; Zhang B; Tian DW; Hu HL; Wu CL
    Medicine (Baltimore); 2017 May; 96(21):e6945. PubMed ID: 28538387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preoperative hydronephrosis as a predictor of postnephroureterectomy survival in patients with upper tract urothelial carcinoma: a two-center study in Japan.
    Fukui T; Kanno T; Kobori G; Moroi S; Yamada H
    Int J Clin Oncol; 2020 Mar; 25(3):456-463. PubMed ID: 31482240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of Perioperative Allogenic Blood Transfusion on Survival After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma.
    Rink M; Soave A; Dahlem R; Aziz A; Al-Sayed F; Peine S; Engel O; Kluth LA; Stenzl A; Burger M; Shariat SF; Fisch M; Fritsche HM; Gakis G
    Clin Genitourin Cancer; 2016 Feb; 14(1):96-104. PubMed ID: 26506908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Macroscopic sessile tumor architecture is a pathologic feature of biologically aggressive upper tract urothelial carcinoma.
    Fritsche HM; Novara G; Burger M; Gupta A; Matsumoto K; Kassouf W; Sircar K; Zattoni F; Walton T; Tritschler S; Baba S; Bastian PJ; Martínez-Salamanca JI; Seitz C; Otto W; Wieland WF; Karakiewicz PI; Ficarra V; Hartmann A; Shariat SF
    Urol Oncol; 2012 Sep; 30(5):666-72. PubMed ID: 20933445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preoperative C-reactive protein to albumin ratio as a novel prognostic biomarker for the oncological outcomes of radical nephroureterectomy.
    Gwak CH; Suh J; Lim B; Song C; You D; Jeong IG; Hong JH; Hong B; Ahn H
    Urol Oncol; 2024 Feb; 42(2):30.e17-30.e23. PubMed ID: 38072737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic impact of preoperative anemia on upper tract urothelial carcinoma.
    Tan P; Xie N; Liao H; Zou L; Xu H; Yang L; Liu L; Wei Q
    Medicine (Baltimore); 2018 Sep; 97(37):e12300. PubMed ID: 30212968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preoperative predictors of nonorgan-confined disease in upper-tract urothelial carcinoma differ between China and the United States.
    Singla N; Fang D; Su X; Bao Z; Cao Z; Robyak H; Xiong G; Zhang L; Woldu S; Hutchinson R; Sagalowsky A; Lotan Y; Li X; Zhou L; Raman JD; Margulis V
    Urol Oncol; 2018 Mar; 36(3):88.e11-88.e18. PubMed ID: 29174945
    [TBL] [Abstract][Full Text] [Related]  

  • 37. What is the Role of the Preoperative Blood-Based Inflammation Biomarkers in the Prognosis of Upper Tract Urothelial Carcinoma With Radical Nephroureterectomy? A Single-Centre Retrospective Study.
    Luo Z; Jiao B; Huang T; Zhao H; Zhang G
    Technol Cancer Res Treat; 2022; 21():15330338221095667. PubMed ID: 35585719
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical significance of prognosis using the neutrophil-lymphocyte ratio and erythrocyte sedimentation rate in patients undergoing radical nephroureterectomy for upper urinary tract urothelial carcinoma.
    Sung HH; Jeon HG; Jeong BC; Seo SI; Jeon SS; Choi HY; Lee HM
    BJU Int; 2015 Apr; 115(4):587-94. PubMed ID: 24947340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic Value of Lymphovascular Invasion in Node-Negative Upper Urinary Tract Urothelial Carcinoma Patients Undergoing Radical Nephroureterectomy.
    Liu W; Zhou Z; Dong D; Sun L; Zhang G
    Yonsei Med J; 2019 Feb; 60(2):174-181. PubMed ID: 30666839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of the ASA Physical Status Score on Adjuvant Chemotherapy Eligibility and Survival of Upper Tract Urothelial Carcinoma Patients: a Multicenter Study.
    Kang HW; Seo SP; Kim WT; Kim YJ; Yun SJ; Lee SC; Choi YD; Ha YS; Kim TH; Kwon TG; Byun SS; Jeh SU; Kim WJ
    J Korean Med Sci; 2017 Feb; 32(2):335-342. PubMed ID: 28049247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.